All Stories

  1. The food grade bacteriumLactobacillus helveticus VEL12193promotes autophagy by releasing membrane vesicles

    Article • October 2024, Cold Spring Harbor Laboratory Press

    Dr Luis G BERMUDEZ-HUMARAN

  2. Probiotic Activity of Lactic Acid Bacteria Isolated from Traditional Mexican Fermented Beverages

    Article • September 2024, Taylor & Francis

    Dr Luis G BERMUDEZ-HUMARAN

  3. Use of Rgg quorum-sensing machinery to create an innovative recombinant protein expression system in Streptococcus thermophilus

    Article • Microbiology, September 2024, Society for General Microbiology

    Dr Luis G BERMUDEZ-HUMARAN

  4. Importance of Probiotics in Fish Aquaculture: Towards the Identification and Design of Novel Probiotics

    Article • Microorganisms, March 2024, MDPI AG

    Dr Luis G BERMUDEZ-HUMARAN

  5. Long-term intake of Lactobacillus helveticus enhances bioavailability of omega-3 fatty acids in the mouse retina

    Article • npj Biofilms and Microbiomes, January 2024, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  6. Impact of Oral Administration of Lactiplantibacillus plantarum Strain CNCM I−4459 on Obesity Induced by High-Fat Diet in Mice

    Article • Bioengineering, October 2023, MDPI AG

    Dr Luis G BERMUDEZ-HUMARAN

  7. Beneficial Effects of Lactobacilli Species on Intestinal Homeostasis in Low-Grade Inflammation and Stress Rodent Models and Their Implication in the Modulation of the Adhesive Junctional Complex

    Article • Biomolecules, August 2023, MDPI AG

    Dr Luis G BERMUDEZ-HUMARAN

  8. Faecalibacterium: a bacterial genus with promising human health applications

    Article • FEMS Microbiology Reviews, July 2023, Oxford University Press (OUP)

    Dr Luis G BERMUDEZ-HUMARAN

  9. Host-microbe interactions mediate doramectin-promoted metabolic reprogramming of CD8+ T-cells and amplify antitumor immunity

    Article • January 2023, Cold Spring Harbor Laboratory Press

    Dr Luis G BERMUDEZ-HUMARAN

  10. Lactic Fermentation of Broccoli (Brassica oleracea var. italica) to Enhance the Antioxidant and Antiproliferative Activities

    Article • Fermentation, January 2023, MDPI AG

    Prof Cristobal N Aguilar, Dr Luis G BERMUDEZ-HUMARAN, Raul Rodriguez-Herrera

  11. Use of genetically modified lactic acid bacteria and bifidobacteria as live delivery vectors for human and animal health

    Article • Gut Microbes, August 2022, Taylor & Francis

    Dr Luis G BERMUDEZ-HUMARAN

  12. Strategies for the Identification and Assessment of Bacterial Strains with Specific Probiotic Traits

    Article • Microorganisms, July 2022, MDPI AG

    Dr Luis G BERMUDEZ-HUMARAN

  13. Effects of a Modern Kefir on Conditions Associated with Moderate Severe Spastic Quadriparesis Cerebral Palsy

    Article • Microorganisms, June 2022, MDPI AG

    Dr Luis G BERMUDEZ-HUMARAN

  14. Functional Foods, Nutraceuticals and Probiotics: A Focus on Human Health

    Article • Microorganisms, May 2022, MDPI AG

    Dr Luis G BERMUDEZ-HUMARAN

  15. Looking inside Mexican Traditional Food as Sources of Synbiotics for Developing Novel Functional Products

    Article • Fermentation, March 2022, MDPI AG

    Dr Luis G BERMUDEZ-HUMARAN

  16. Genome Sequence and Assessment of Safety and Potential Probiotic Traits of Lactobacillus johnsonii CNCM I-4884

    Article • Microorganisms, January 2022, MDPI AG

    Dr Luis G BERMUDEZ-HUMARAN

  17. Probiotics against Viral Infections: Current Clinical Trials and Future Perspectives

    Article • Immuno, November 2021, MDPI AG

    Dr Luis G BERMUDEZ-HUMARAN

  18. Probiotics and Trained Immunity

    Article • Biomolecules, September 2021, MDPI AG

    Dr Luis G BERMUDEZ-HUMARAN

  19. Age and Giardia intestinalis Infection Impact Canine Gut Microbiota

    Article • Microorganisms, September 2021, MDPI AG

    Dr Luis G BERMUDEZ-HUMARAN

  20. Bioactive Compounds in Food as a Current Therapeutic Approach to Maintain a Healthy Intestinal Epithelium

    Article • Microorganisms, July 2021, MDPI AG

    Dr Luis G BERMUDEZ-HUMARAN

  21. Antioxidant and Anti-Inflammatory Properties of Probiotic Candidate Strains Isolated during Fermentation of Agave (Agave angustifolia Haw)

    Article • Microorganisms, May 2021, MDPI AG

    Dr Luis G BERMUDEZ-HUMARAN

  22. Anti-microbiota vaccines modulate the tick microbiome in a taxon-specific manner

    Article • May 2021, Cold Spring Harbor Laboratory Press

    Dr Luis G BERMUDEZ-HUMARAN

  23. Role of Gut Microbiota and Probiotics in Colorectal Cancer: Onset and Progression

    Article • Microorganisms, May 2021, MDPI AG

    Dr Luis G BERMUDEZ-HUMARAN

  24. Probiotic-Based Vaccines May Provide Effective Protection against COVID-19 Acute Respiratory Disease

    Article • Vaccines, May 2021, MDPI AG

    Dr Luis G BERMUDEZ-HUMARAN

  25. Modulation of the PI3K/Akt/mTOR signaling pathway by probiotics as a fruitful target for orchestrating the immune response

    Article • Gut Microbes, January 2021, Taylor & Francis

    Dr Luis G BERMUDEZ-HUMARAN

  26. Butyrate mediates anti-inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3

    Article • Gut Microbes, October 2020, Taylor & Francis

    Dr Luis G BERMUDEZ-HUMARAN

  27. Identification of sulfur components enhancing the anti-Candida effect of Lactobacillus rhamnosus Lcr35

    Article • Scientific Reports, October 2020, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  28. Twenty years of research on HPV vaccines based on genetically modified lactic acid bacteria: an overview on the gut-vagina axis

    Article • Cellular and Molecular Life Sciences, September 2020, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  29. Protective Effect of Glycomacropeptide on Food Allergy with Gastrointestinal Manifestations in a Rat Model through Down-Regulation of Type 2 Immune Response

    Article • Nutrients, September 2020, MDPI AG

    Dr Luis G BERMUDEZ-HUMARAN

  30. Retraction Note to: Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer

    Article • Journal of Gastroenterology, September 2020, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  31. The Administration Matrix Modifies the Beneficial Properties of a Probiotic Mix of Bifidobacterium animalis subsp. lactis BB-12 and Lactobacillus acidophilus LA-5

    Article • Probiotics and Antimicrobial Proteins, August 2020, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  32. Evaluation of the Probiotic Properties and the Capacity to Form Biofilms of Various Lactobacillus Strains

    Article • Microorganisms, July 2020, MDPI AG

    Dr Luis G BERMUDEZ-HUMARAN, Dr Angel Gil-Izquierdo

  33. Gut Microbiota Abrogates Anti-α-Gal IgA Response in Lungs and Protects against Experimental Aspergillus Infection in Poultry

    Article • Vaccines, June 2020, MDPI AG

    Dr Luis G BERMUDEZ-HUMARAN

  34. Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes

    Article • Diabetes Research and Clinical Practice, June 2020, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  35. Butyrate mediates anti-inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3

    Article • May 2020, Research Square

    Dr Luis G BERMUDEZ-HUMARAN

  36. Targeting Melanoma Hypoxia with the Food-Grade Lactic Acid Bacterium Lactococcus Lactis

    Article • Cancers, February 2020, MDPI AG

    Dr Luis G BERMUDEZ-HUMARAN

  37. Probiotics as Anti-Giardia Defenders: Overview on Putative Control Mechanisms

    Article • January 2020, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  38. Probiotic Properties of Lactobacillus Strains Isolated from Table Olive Biofilms

    Article • Probiotics and Antimicrobial Proteins, December 2019, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  39. Abdominoplasty in Hemodialysis Patients Before Transplant

    Article • Experimental and Clinical Transplantation, October 2019, Baskent University

    Dr Luis G BERMUDEZ-HUMARAN

  40. Oral delivery of pancreatitis‐associated protein by Lactococcus lactis displays protective effects in dinitro‐benzenesulfonic‐acid‐induced colitis model and is able to modulate the composition of the microbiota

    Article • Environmental Microbiology, September 2019, Wiley

    Dr Luis G BERMUDEZ-HUMARAN

  41. From Probiotics to Psychobiotics: Live Beneficial Bacteria Which Act on the Brain-Gut Axis

    Article • Nutrients, April 2019, MDPI AG

    Dr Luis G BERMUDEZ-HUMARAN

  42. Phosphatidylglycerols are novel lipids dysregulated in obesity

    Article • The FASEB Journal, April 2019, Federation of American Societies For Experimental Biology (FASEB)

    Isabelle Dugail, Anatol Kontush, Dr Luis G BERMUDEZ-HUMARAN

  43. The potential probiotic Lactobacillus rhamnosus CNCM I-3690 strain protects the intestinal barrier by stimulating both mucus production and cytoprotective response

    Article • Scientific Reports, April 2019, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  44. Anti-tumoral Effects of Recombinant Lactococcus lactis Strain Secreting IL-17A Cytokine

    Article • Frontiers in Microbiology, January 2019, Frontiers

    Dr Luis G BERMUDEZ-HUMARAN

  45. Elucidating the Immune-Related Mechanisms by Which Probiotic Strain Lactobacillus casei BL23 Displays Anti-tumoral Properties

    Article • Frontiers in Microbiology, January 2019, Frontiers

    Dr Luis G BERMUDEZ-HUMARAN

  46. A New Bifidobacteria Expression SysTem (BEST) to Produce and Deliver Interleukin-10 in Bifidobacterium bifidum

    Article • Frontiers in Microbiology, December 2018, Frontiers

    Dr Luis G BERMUDEZ-HUMARAN

  47. M cell–targeting strategy enhances systemic and mucosal immune responses induced by oral administration of nuclease-producing L. lactis

    Article • Applied Microbiology and Biotechnology, October 2018, Springer Science + Business Media

    Professor Naoki Inoue, Dr Luis G BERMUDEZ-HUMARAN

  48. Gut microbiome modulation during treatment of mucositis with the dairy bacterium Lactococcus lactis and recombinant strain secreting human antimicrobial PAP

    Article • Scientific Reports, October 2018, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  49. Live bacterial biotherapeutics in the clinic

    Article • Nature Biotechnology, October 2018, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  50. Latency and amplitude changes in cognitive event related potentials due to hemodialysis

    Article • July 2018, Institute of Electrical & Electronics Engineers (IEEE)

    Dr Luis G BERMUDEZ-HUMARAN

  51. Increased gut permeability in cancer cachexia: mechanisms and clinical relevance

    Article • Oncotarget, April 2018, Impact Journals, LLC

    Dr Luis G BERMUDEZ-HUMARAN

  52. A Versatile New Model of Chemically Induced Chronic Colitis Using an Outbred Murine Strain

    Article • Frontiers in Microbiology, March 2018, Frontiers

    Dr Luis G BERMUDEZ-HUMARAN

  53. Searching for the Bacterial Effector: The Example of the Multi-Skilled Commensal Bacterium Faecalibacterium prausnitzii

    Article • Frontiers in Microbiology, March 2018, Frontiers

    Dr Luis G BERMUDEZ-HUMARAN

  54. Bile Salt Hydrolase Activities: A Novel Target to Screen Anti-Giardia Lactobacilli?

    Article • Frontiers in Microbiology, February 2018, Frontiers

    Dr Luis G BERMUDEZ-HUMARAN

  55. Bile-Salt-Hydrolases from the Probiotic Strain Lactobacillus johnsonii La1 Mediate Anti-giardial Activity in Vitro and in Vivo

    Article • Frontiers in Microbiology, January 2018, Frontiers

    Dr Luis G BERMUDEZ-HUMARAN

  56. Use of Traditional and Genetically Modified Probiotics in Human Health: What Does the Future Hold?

    Article • January 2018, ASM Journals

    Dr Luis G BERMUDEZ-HUMARAN

  57. Probiotic Strain Lactobacillus casei BL23 Prevents Colitis-Associated Colorectal Cancer

    Article • Frontiers in Immunology, November 2017, Frontiers

    Dr Luis G BERMUDEZ-HUMARAN

  58. New Insights into the Diversity of the Genus Faecalibacterium

    Article • Frontiers in Microbiology, September 2017, Frontiers

    Dr Luis G BERMUDEZ-HUMARAN

  59. Use of Traditional and Genetically Modified Probiotics in Human Health: What Does the Future Hold?

    Article • Microbiology Spectrum, September 2017, ASM Journals

    Dr Luis G BERMUDEZ-HUMARAN

  60. Functional Characterization of Novel Faecalibacterium prausnitzii Strains Isolated from Healthy Volunteers: A Step Forward in the Use of F. prausnitzii as a Next-Generation Probiotic

    Article • Frontiers in Microbiology, June 2017, Frontiers

    Dr Luis G BERMUDEZ-HUMARAN

  61. Use of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis

    Article • Frontiers in Microbiology, May 2017, Frontiers

    Dr Luis G BERMUDEZ-HUMARAN

  62. Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria

    Article • Microbial Cell Factories, May 2017, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  63. Contribution of sortase SrtA2 to Lactobacillus casei BL23 inhibition of Staphylococcus aureus internalization into bovine mammary epithelial cells

    Article • PLoS ONE, March 2017, PLOS

    Dr Luis G BERMUDEZ-HUMARAN

  64. Secretion of biologically active pancreatitis-associated protein I (PAP) by genetically modified dairy Lactococcus lactis NZ9000 in the prevention of intestinal mucositis

    Article • Microbial Cell Factories, February 2017, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  65. Anti-cancer effect of lactic acid bacteria expressing antioxidant enzymes or IL-10 in a colorectal cancer mouse model

    Article • International Immunopharmacology, January 2017, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  66. The use of Mexican xaxtle as leavening agent in Italian straight dough bread making to produce pulque bread

    Article • AGROCHIMICA, January 2017, Pisa University Press

    Dr Luis G BERMUDEZ-HUMARAN

  67. Screening of probiotic strains to improve visceral hypersensitivity in irritable bowel syndrome by using in vitro and in vivo approaches

    Article • Beneficial Microbes, January 2017, Brill

    Dr Luis G BERMUDEZ-HUMARAN

  68. Assessment of the safety of Levilactobacillus brevis CNCM I-5321, a probiotic candidate strain isolated from pulque with anti-proliferative activities

    Article • Beneficial Microbes, January 2017, Brill

    Dr Luis G BERMUDEZ-HUMARAN

  69. Erratum to: Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse model

    Article • Microbial Cell Factories, November 2016, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  70. Evaluation of the biosafety of recombinant lactic acid bacteria designed to prevent and treat colitis

    Article • Journal of Medical Microbiology, September 2016, Society for General Microbiology

    Dr Luis G BERMUDEZ-HUMARAN

  71. Metagenomic analysis of the human microbiome

    Article • August 2016, Wiley

    Dr Luis G BERMUDEZ-HUMARAN

  72. Brief cognitive behavioural intervention for depression and anxiety symptoms improves quality of life in chronic haemodialysis patients

    Article • Psychology and Psychotherapy Theory Research and Practice, July 2016, Wiley

    Dr Luis G BERMUDEZ-HUMARAN

  73. A large scale in vitro screening of Streptococcus thermophilus strains revealed strains with a high anti-inflammatory potential

    Article • LWT, July 2016, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  74. Bifidobacterium animalis ssp. lactis CNCM-I2494 Restores Gut Barrier Permeability in Chronically Low-Grade Inflamed Mice

    Article • Frontiers in Microbiology, May 2016, Frontiers

    Dr Luis G BERMUDEZ-HUMARAN

  75. A new lactobacilliin vivoexpression system for the production and delivery of heterologous proteins at mucosal surfaces

    Article • FEMS Microbiology Letters, May 2016, Oxford University Press (OUP)

    Dr Luis G BERMUDEZ-HUMARAN

  76. Gnotobiotic Rodents: An In Vivo Model for the Study of Microbe–Microbe Interactions

    Article • Frontiers in Microbiology, March 2016, Frontiers

    Dr Luis G BERMUDEZ-HUMARAN

  77. Expression of fibronectin binding protein A (FnBPA) from Staphylococcus aureus at the cell surface of Lactococcus lactis improves its immunomodulatory properties when used as protein delivery vector

    Article • Vaccine, March 2016, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  78. Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models

    Article • Scientific Reports, January 2016, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  79. Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer

    Article • Journal of Gastroenterology, January 2016, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  80. The secreted l-arabinose isomerase displays anti-hyperglycemic effects in mice

    Article • Microbial Cell Factories, December 2015, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  81. Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse model

    Article • Microbial Cell Factories, November 2015, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  82. Drying process strongly affects probiotics viability and functionalities

    Article • Journal of Biotechnology, November 2015, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  83. Identification of novel anti-inflammatory probiotic strains isolated from pulque

    Article • Applied Microbiology and Biotechnology, October 2015, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  84. Engineering Lactic Acid Bacteria and Bifidobacteria for Mucosal Delivery of Health Molecules

    Article • September 2015, Wiley

    Dr Luis G BERMUDEZ-HUMARAN

  85. Identification of an anti-inflammatory protein fromFaecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease

    Article • Gut, June 2015, BMJ

    Dr Luis G BERMUDEZ-HUMARAN

  86. Identification of Metabolic Signatures Linked to Anti-Inflammatory Effects of Faecalibacterium prausnitzii

    Article • mBio, April 2015, ASM Journals

    Dr Luis G BERMUDEZ-HUMARAN

  87. Intranasal administration with recombinant Lactococcus lactis expressing heme oxygenase-1 reduces hyperoxia-induced lung inflammation in rat pups

    Article • Biotechnology Letters, April 2015, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  88. Effect of iron on the probiotic properties of the vaginal isolate Lactobacillus jensenii CECT 4306

    Article • Microbiology, April 2015, Society for General Microbiology

    Dr Luis G BERMUDEZ-HUMARAN

  89. Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model

    Article • BMC Microbiology, March 2015, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  90. Milk Fermented with a 15-Lipoxygenase-1-Producing Lactococcus Lactis Alleviates Symptoms of colitis in a Murine Model

    Article • Current Pharmaceutical Biotechnology, March 2015, Bentham Science Publishers

    Dr Luis G BERMUDEZ-HUMARAN, Dr Vasco Azevedo

  91. Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci

    Article • Microbial Cell Factories, February 2015, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  92. Construction d’un vecteur d’expression chez Lactococcus lactis basée sur la production d’une protéine ancrée de Papillomavirus humain 16 E2/E7

    Article • Journal africain du cancer / African Journal of Cancer, February 2015, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  93. Lactobacillus rhamnosusCNCM I-3690 and the commensal bacteriumFaecalibacterium prausnitziiA2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice

    Article • Gut Microbes, January 2015, Taylor & Francis

    Dr Luis G BERMUDEZ-HUMARAN

  94. Current Review of Genetically Modified Lactic Acid Bacteria for the Prevention and Treatment of Colitis Using Murine Models

    Article • Gastroenterology Research and Practice, January 2015, Hindawi Publishing Corporation

    Dr Luis G BERMUDEZ-HUMARAN

  95. The Indigenous Microbiota and its Potential to Exhibit Probiotic Properties

    Article • January 2015, Caister Academic Press

    Dr Luis G BERMUDEZ-HUMARAN

  96. Protective Effects of Lactococci Strains Delivering Either IL-10 Protein or cDNA in a TNBS-induced Chronic Colitis Model

    Article • Journal of Clinical Gastroenterology, November 2014, Wolters Kluwer Health

    Dr Luis G BERMUDEZ-HUMARAN

  97. Selection of Anti-Inflammatory Lactic Acid Bacteria From A Pool of Yoghurt Starter Cultures

    Article • November 2014, Editora Edgard Blucher, Ltda.

    Dr Luis G BERMUDEZ-HUMARAN

  98. Gut ecosystem: how microbes help us

    Article • Beneficial Microbes, September 2014, Wageningen Academic Publishers

    Dr Luis G BERMUDEZ-HUMARAN

  99. The Dual Role of MAPK Pathway in the Regulation of Intestinal Barrier

    Article • Inflammatory Bowel Diseases, July 2014, Wolters Kluwer Health

    Dr Luis G BERMUDEZ-HUMARAN

  100. Tu1778 Faecalibacterium prausnitzii Prevents Irritable Bowel Syndrome-Like Symptoms in Both Murine Low Grade Chronic Inflammation and Acute Stress Models

    Article • Gastroenterology, May 2014, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  101. Tu1746 Faecalibacterium prausnitzii Provides Host Beneficial Metabolic Profile During Inflammation

    Article • Gastroenterology, May 2014, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  102. 83 Identification of an Anti-Inflammatory Protein From Faecalibacterium prausnitzii, a Deficient Commensal Bacteria Implicated in Crohn's Disease

    Article • Gastroenterology, May 2014, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  103. Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation

    Article • Human Vaccines & Immunotherapeutics, April 2014, Taylor & Francis

    Dr Luis G BERMUDEZ-HUMARAN

  104. Novel Role of the Serine Protease Inhibitor Elafin in Gluten-Related Disorders

    Article • The American Journal of Gastroenterology, April 2014, Wolters Kluwer Health

    Dr Luis G BERMUDEZ-HUMARAN

  105. The Commensal Bacterium Faecalibacterium prausnitzii Is Protective in DNBS-induced Chronic Moderate and Severe Colitis Models

    Article • Inflammatory Bowel Diseases, March 2014, Wolters Kluwer Health

    Dr Luis G BERMUDEZ-HUMARAN

  106. The role of metagenomics in understanding the human microbiome in health and disease

    Article • Virulence, February 2014, Taylor & Francis

    Dr Luis G BERMUDEZ-HUMARAN

  107. Ecology and metabolism of the beneficial intestinal commensal bacteriumFaecalibacterium prausnitzii

    Article • Gut Microbes, January 2014, Taylor & Francis

    Dr Luis G BERMUDEZ-HUMARAN

  108. Genetically Engineered Immunomodulatory Streptococcus thermophilus Strains Producing Antioxidant Enzymes Exhibit Enhanced Anti-Inflammatory Activities

    Article • Applied and Environmental Microbiology, November 2013, ASM Journals

    Dr Luis G BERMUDEZ-HUMARAN

  109. Development of a Stress-Inducible Controlled Expression (SICE) system in Lactococcus lactis for the production and delivery of therapeutic molecules at mucosal surfaces

    Article • Journal of Biotechnology, October 2013, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  110. Nuclease A (Gbs0661), an extracellular nuclease ofStreptococcus agalactiae, attacks the neutrophil extracellular traps and is needed for full virulence

    Article • Molecular Microbiology, July 2013, Wiley

    Dr Luis G BERMUDEZ-HUMARAN

  111. Engineering lactococci and lactobacilli for human health

    Article • Current Opinion in Microbiology, June 2013, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  112. Faecalibacterium prausnitzii and human intestinal health

    Article • Current Opinion in Microbiology, June 2013, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  113. Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an update

    Article • FEMS Microbiology Letters, May 2013, Oxford University Press (OUP)

    Dr Luis G BERMUDEZ-HUMARAN

  114. Tu1988 Impact of the Commensal Bacterium Faecalibacterium prausnitzii in a Non Active Inflammation Murine Model

    Article • Gastroenterology, May 2013, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  115. Implications of the human microbiome in inflammatory bowel diseases

    Article • FEMS Microbiology Letters, March 2013, Oxford University Press (OUP)

    Dr Luis G BERMUDEZ-HUMARAN

  116. Erratum to: Protection against human papillomavirus type 16-induced tumors in mice using non-genetically modified lactic acid bacteria displaying E7 antigen at its surface

    Article • Applied Microbiology and Biotechnology, January 2013, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  117. Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease

    Article • Microbial Cell Factories, January 2013, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  118. Anti-Inflammatory Properties of Genetically Modified Lactic Acid Bacteria

    Article • January 2013, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  119. Contributors

    Article • January 2013, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  120. Identification of One Novel Candidate Probiotic Lactobacillus plantarum Strain Active against Influenza Virus Infection in Mice by a Large-Scale Screening

    Article • Applied and Environmental Microbiology, December 2012, ASM Journals

    Dr Luis G BERMUDEZ-HUMARAN

  121. Protection against human papillomavirus type 16-induced tumors in mice using non-genetically modified lactic acid bacteria displaying E7 antigen at its surface

    Article • Applied Microbiology and Biotechnology, December 2012, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  122. Food-Grade Bacteria Expressing Elafin Protect Against Inflammation and Restore Colon Homeostasis

    Article • Science Translational Medicine, October 2012, American Association for the Advancement of Science

    Dr Luis G BERMUDEZ-HUMARAN

  123. Functional Analysis of the Lactobacillus casei BL23 Sortases

    Article • Applied and Environmental Microbiology, October 2012, ASM Journals

    Dr Luis G BERMUDEZ-HUMARAN, Dr Jesús Rodríguez Díaz

  124. Inactivation of theybdDGene in Lactococcus lactis Increases the Amounts of Exported Proteins

    Article • Applied and Environmental Microbiology, July 2012, ASM Journals

    Dr Luis G BERMUDEZ-HUMARAN

  125. Importance of Commensal and Probiotic Bacteria in Human Health

    Article • Current Immunology Reviews, May 2012, Bentham Science Publishers

    Dr Luis G BERMUDEZ-HUMARAN

  126. Mo1855 Oral Treatment With Elafin-Recombinant Probiotics Improves Visceral Pain and Hypersensitivity in a Model of Irritable Bowel Syndrome (IBS)

    Article • Gastroenterology, May 2012, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  127. Mo2015 Food-Grade Lactic Acid Bacteria Expressing Elastase Inhibitors Protect From Intestinal Inflammation in Acute and Chronic Models of Colitis in Mice

    Article • Gastroenterology, May 2012, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  128. Sa2060 Gnotobiotic Mice, a Promising Tool to Better Understand the Anti-Inflammatory Effects of Faecalibacterium prausnitziï?

    Article • Gastroenterology, May 2012, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  129. Sa2061 Protective and Curative Effect of Faecalibacterium prausnitzii in a Chronic DNBS-Induced Murine Colitis

    Article • Gastroenterology, May 2012, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  130. Tu1842 Elastolytic Balance in IBD: the Elastase Inhibitor Elafin Prevents Loss of Barrier Function and Cytokines Release by Human Intestinal Epithelial Cells in IBD Conditions

    Article • Gastroenterology, May 2012, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  131. Anti-inflammatory properties of dairy lactobacilli

    Article • Inflammatory Bowel Diseases, April 2012, Oxford University Press (OUP)

    Dr Luis G BERMUDEZ-HUMARAN

  132. Mucosal co-immunization of mice with recombinant lactococci secreting VapA antigen and leptin elicits a protective immune response against Rhodococcus equi infection

    Article • Vaccine, December 2011, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  133. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment

    Article • EMBO Molecular Medicine, August 2011, EMBO

    Dr Luis G BERMUDEZ-HUMARAN

  134. Use of superoxide dismutase and catalase producing lactic acid bacteria in TNBS induced Crohn's disease in mice

    Article • Journal of Biotechnology, February 2011, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  135. Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines

    Article • Microbial Cell Factories, January 2011, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  136. Variations of N-acetylation level of peptidoglycan do not influence persistence of Lactococcus lactis in the gastrointestinal tract

    Article • International Journal of Food Microbiology, November 2010, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  137. Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice

    Article • International Journal of Food Microbiology, November 2010, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  138. Perspectives for the development of human papillomavirus vaccines and immunotherapy

    Article • Expert Review of Vaccines, January 2010, Taylor & Francis

    Dr Luis G BERMUDEZ-HUMARAN

  139. Utilisation des bactéries lactiques comme vecteurs vaccinaux

    Article • Revue Francophone des Laboratoires, December 2009, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  140. Protective Effects of a Heme Oxygenase-1-Secreting Lactococcus lactis on Mucosal Injury Induced by Hemorrhagic Shock in Rats

    Article • Journal of Surgical Research, May 2009, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  141. Lactococcus lactisas a live vector for mucosal delivery of therapeutic proteins

    Article • Human Vaccines, April 2009, Taylor & Francis

    Dr Luis G BERMUDEZ-HUMARAN

  142. Development of Mucosal Vaccines Based on Lactic Acid Bacteria

    Article • January 2009, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  143. Heterologous production of human papillomavirus type-16 L1 protein by a lactic acid bacterium

    Article • BMC Research Notes, January 2009, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  144. Allergy Therapy by Intranasal Administration with Recombinant Lactococcus lactis Producing Bovine β-Lactoglobulin

    Article • International Archives of Allergy and Immunology, January 2009, Karger Publishers

    Dr Luis G BERMUDEZ-HUMARAN

  145. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

    Article • Proceedings of the National Academy of Sciences, October 2008, Proceedings of the National Academy of Sciences

    Dr Luis G BERMUDEZ-HUMARAN

  146. Production of biologically active CXC chemokines by Lactococcus lactis: Evaluation of its potential as a novel mucosal vaccine adjuvant

    Article • Vaccine, October 2008, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  147. Anti-inflammatory Properties of Lactic Acid Bacteria: Current Knowledge,Applications and Prospects

    Article • Anti-Infective Agents in Medicinal Chemistry, July 2008, Bentham Science Publishers

    Dr Luis G BERMUDEZ-HUMARAN

  148. Intragastric administration with recombinant Lactococcus lactis producing heme oxygenase-1 prevents lipopolysaccharide-induced endotoxemia in rats

    Article • FEMS Microbiology Letters, April 2008, Oxford University Press (OUP)

    Dr Luis G BERMUDEZ-HUMARAN

  149. Production of biological active murine IFN-γ by recombinant Lactococcus lactis

    Article • FEMS Microbiology Letters, March 2008, Oxford University Press (OUP)

    Dr Luis G BERMUDEZ-HUMARAN

  150. Consumption of Camembert cheese stimulates commensal enterococci in healthy human intestinal microbiota

    Article • FEMS Microbiology Letters, November 2007, Oxford University Press (OUP)

    Dr Luis G BERMUDEZ-HUMARAN

  151. Current Prophylactic and Therapeutic Uses of a Recombinant Lactococcus lactis Strain Secreting Biologically Active Interleukin-12

    Article • Journal of Molecular Microbiology and Biotechnology, October 2007, Karger Publishers

    Dr Luis G BERMUDEZ-HUMARAN

  152. Lactococcus lactis, an Efficient Cell Factory for Recombinant Protein Production and Secretion

    Article • Journal of Molecular Microbiology and Biotechnology, October 2007, Karger Publishers

    Dr Luis G BERMUDEZ-HUMARAN

  153. Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria

    Article • Vaccine, September 2007, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  154. Effects of Intranasal Administration of a Leptin-Secreting Lactococcus lactis Recombinant on Food Intake, Body Weight, and Immune Response of Mice

    Article • Applied and Environmental Microbiology, June 2007, ASM Journals

    Dr Luis G BERMUDEZ-HUMARAN

  155. Intranasal Coadministration of Live Lactococci Producing Interleukin-12 and a Major Cow's Milk Allergen Inhibits Allergic Reaction in Mice

    Article • Clinical and Vaccine Immunology, January 2007, ASM Journals

    Dr Luis G BERMUDEZ-HUMARAN

  156. Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependant catalase on DSS-induced colitis in mice

    Article • Microbial Cell Factories, January 2007, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  157. Antimicrobial Activity of Divercin RV41 Produced and Secreted by Lactococcus lactis

    Article • Journal of Molecular Microbiology and Biotechnology, January 2007, Karger Publishers

    Dr Luis G BERMUDEZ-HUMARAN

  158. Construction and characterization of a Lactococcus lactis strain deficient in intracellular ClpP and extracellular HtrA proteases

    Article • Microbiology, September 2006, Society for General Microbiology

    Dr Luis G BERMUDEZ-HUMARAN

  159. Des bactéries pour prévenir et traiter le cancer du col de l’utérus induit par le papillomavirus humain de type 16

    Article • médecine/sciences, May 2006, EDP Sciences

    Dr Luis G BERMUDEZ-HUMARAN

  160. Immunomodulatory effects of IL-12 secreted by Lactococcus lactis on Th1/Th2 balance in ovalbumin (OVA)-induced asthma model mice

    Article • International Immunopharmacology, April 2006, Elsevier

    Dr Luis G BERMUDEZ-HUMARAN

  161. Article • Microbial Cell Factories, January 2006, Springer Science + Business Media

    Dr Vasco Azevedo, Dr Luis G BERMUDEZ-HUMARAN

  162. A Novel Mucosal Vaccine Based on Live Lactococci Expressing E7 Antigen and IL-12 Induces Systemic and Mucosal Immune Responses and Protects Mice against Human Papillomavirus Type 16-Induced Tumors

    Article • The Journal of Immunology, November 2005, The American Association of Immunologists

    Dr Luis G BERMUDEZ-HUMARAN

  163. Improvement of bovine ß-lactoglobulin production and secretion by Lactococcus lactis

    Article • March 2005, FapUNIFESP (SciELO)

    Dr Luis G BERMUDEZ-HUMARAN

  164. Cell-surface display of E7 antigen from human papillomavirus type-16 inLactococcus lactisand inLactobacillus plantarumusing a new cell-wall anchor from lactobacilli

    Article • Journal of Drug Targeting, February 2005, Taylor & Francis

    Dr Luis G BERMUDEZ-HUMARAN

  165. Article • Microbial Cell Factories, January 2005, Springer Science + Business Media

    Dr Luis G BERMUDEZ-HUMARAN

  166. An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci

    Article • Journal of Medical Microbiology, May 2004, Society for General Microbiology

    Dr Luis G BERMUDEZ-HUMARAN

  167. Article

    Article • Dairy Science & Technology, January 2004, EDP Sciences

    Dr Luis G BERMUDEZ-HUMARAN

  168. Mice immunization with live lactococci displaying a surface anchored HPV-16 E7 oncoprotein

    Article • FEMS Microbiology Letters, December 2003, Oxford University Press (OUP)

    Dr Luis G BERMUDEZ-HUMARAN

  169. Controlled intra- or extracellular production of staphylococcal nuclease and ovine omega interferon inLactococcus lactis

    Article • FEMS Microbiology Letters, July 2003, Oxford University Press (OUP)

    Dr Luis G BERMUDEZ-HUMARAN

  170. Fusion to a Carrier Protein and a Synthetic Propeptide Enhances E7 HPV-16 Production and Secretion in Lactococcus lactis

    Article • Biotechnology Progress, June 2003, Wiley

    Dr Luis G BERMUDEZ-HUMARAN

  171. Intranasal Immunization with Recombinant Lactococcus lactis Secreting Murine Interleukin-12 Enhances Antigen-Specific Th1 Cytokine Production

    Article • Infection and Immunity, April 2003, ASM Journals

    Dr Luis G BERMUDEZ-HUMARAN

  172. Loss of Restriction Site DdeI, used for Avian Molecular Sexing, in Oreophasis derbianus

    Article • Reproduction in Domestic Animals, December 2002, Wiley

    Dr Luis G BERMUDEZ-HUMARAN

  173. Controlled Production of Stable Heterologous Proteins in Lactococcus lactis

    Article • Applied and Environmental Microbiology, June 2002, ASM Journals

    Dr Luis G BERMUDEZ-HUMARAN

  174. Molecular sexing of monomorphic endangeredArabirds

    Article • The Journal of Experimental Zoology, April 2002, Wiley

    Dr Luis G BERMUDEZ-HUMARAN

  175. Production of Human Papillomavirus Type 16 E7 Protein in Lactococcus lactis

    Article • Applied and Environmental Microbiology, February 2002, ASM Journals

    Dr Luis G BERMUDEZ-HUMARAN